Reuters logo
BRIEF-Galectin Therapeutics receives notice of Chinese allowance to grant a key patent for composition of matter for GR-MD-02
September 12, 2017 / 12:36 PM / in 2 months

BRIEF-Galectin Therapeutics receives notice of Chinese allowance to grant a key patent for composition of matter for GR-MD-02

Sept 12 (Reuters) - Galectin Therapeutics Inc

* Galectin Therapeutics receives notice of Chinese allowance to grant a key patent for composition of matter for GR-MD-02

* Galectin Therapeutics Inc - patent coverage period extends through 2032 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below